CE-Meloxicam

CE-Meloxicam is a pharmaceutical product whose specific composition and formulation cannot be reliably identified in publicly available references; based on the name, it is likely related to the nonsteroidal anti-inflammatory drug meloxicam, an oxicam-class NSAID that preferentially inhibits cyclooxygenase-2 (COX-2) over cyclooxygenase-1 (COX-1) to reduce prostaglandin synthesis, thereby providing analgesic, anti-inflammatory, and antipyretic effects in conditions such as osteoarthritis and rheumatoid arthritis.[1][3][5] Without definitive information on CE-Meloxicam itself, details such as its exact developer, formulation, and approved indications remain uncertain.